Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,5 Disubstituted Pyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111518021A details a metal-free route to 3,5-disubstituted pyridines using styrenes and DMF, offering cost-effective pharma intermediate manufacturing.
Patent CN111592486B reveals a metal-free route to 3,5-diarylpyridines using styrene and DMF, offering significant cost and supply chain advantages for API intermediates.
Novel metal-free cyclization of aryl ethylene and DMF yields high-purity 3,5-disubstituted pyridines. Cost-effective route for API intermediates with scalable production capabilities.
Patent CN111518021B reveals a novel iodide-catalyzed oxidative cyclization using styrene and DMF, offering a cost-effective, metal-free route for high-purity pharmaceutical intermediates.